ProShare Advisors LLC ZVRA KEMPHARM INC

Ownership history in ProShare Advisors LLC  ·  8 quarters on record

AI Ownership Summary

ProShare Advisors LLC reported KEMPHARM INC (ZVRA) in 8 quarterly 13F filings from 2024 Q2 through 2026 Q1. The latest visible filing shows ZVRA at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this ZVRA ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was ProShare Advisors LLC's position in KEMPHARM INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

ZVRA was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2024 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q2 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How ProShare Advisors LLC held ZVRA — position size vs. price
% of Fund (quarterly)    ZVRA price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED 10,594 -2,075 -16.4% 0.00% $99K 2026-04-27 $9.81
2025 Q4 ADDED 12,669 +1,390 +12.3% 0.00% $114K 2026-02-06 $8.60
2025 Q3 REDUCED 14.4% -7.3% 11,279 -1,892 -14.4% 0.00% $107K 2025-11-06 $9.09
2025 Q2 REDUCED 6.1% +8.3% 13,171 -851 -6.1% 0.00% $116K 2025-08-07 $12.13
2025 Q1 REDUCED 19.5% +17.6% 14,022 -3,403 -19.5% 0.00% $105K 2025-05-08 $7.79
2024 Q4 ADDED 17,425 +12,554 +257.7% 0.00% $145K 2025-02-14 $8.07
2024 Q2 REDUCED 57.5% +41.6% 4,871 -6,581 -57.5% 0.00% $24K 2024-08-13 $6.78
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About ProShare Advisors LLC and ZVRA

These are the practical questions this page is built to answer before you even open the full history table.

How long has ProShare Advisors LLC reported owning ZVRA?

ProShare Advisors LLC reported ZVRA across 7 quarterly 13F filings, from 2024 Q2 through 2026 Q1.

What was the largest reported ZVRA position in ProShare Advisors LLC's portfolio?

The largest reported portfolio weight for ZVRA was 0.00% in 2024 Q4.

What is the latest reported ZVRA position on this page?

The most recent filing on this page is 2026 Q1, when ProShare Advisors LLC reported 10,594 shares, equal to 0.00% of portfolio, with an estimated market value of $99K.

What does the chart on this ZVRA ownership page compare?

The chart compares ProShare Advisors LLC's quarterly ZVRA portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did ProShare Advisors LLC time their ZVRA position?

Based on 13F filing dates vs. subsequent ZVRA price moves, ProShare Advisors LLC correctly timed 4 out of 7 reported position changes (57%). The annualised alpha on ZVRA relative to SPY over the holding period was +1.1%.

← Back to ProShare Advisors LLC Holdings